Focused on commercialising speciality medicines.
Consumer healthcare and prescription medicine channels.
UK, Europe USA and Far East.
Covestus Group
Specialty Pharmaceuticals
Consumer Healthcare E-Commerce
Consumer Healthcare E-Commerce
Focused on commercialisation of specialty medicines
DHP Healthcare established in 1959 was acquired by Covestus in 2018, & divested in 2023 to Wyntra Pharmaceuticals
Markets a portfolio of niche prescription, consumer medicines and medical devices.
Consumer Healthcare E-Commerce
Consumer Healthcare E-Commerce
Consumer Healthcare E-Commerce
'No Sweat' consumer products
Established in 2006 in the UK to discover, develop and make available online more effective specialist products for excessive sweating sufferers (Hyperhidrosis)
Owns, licences and markets a range of clinical strength anti-perspirants/ deodorants, iontophoresis medical devices and personal care products.
Operations Strategy
Specialist Partners
Covestus operations are delivered successfully using third-party specialist partners who are managed centrally by our experienced management team. This includes regulatory & medical affairs, quality & safety, manufacturing, sales & marketing, financial & legal.
Platforms
Our portfolio companies offer healthcare platforms that enable us to build on both traditional pharmaceutical commercialisation and e-commerce routes, providing trusted treatments and diagnostics for patients and consumers.
Designed to drive Growth
Our business model is designed to drive acquisiton and organic growth whilst delivering regulatory and quality compliance across all products and services. Operational synergies are sought and implemented when acquiring new businesses. Covestus has significant experience of managing complex business transitions on M&A deals and integration activities.
Business Development Strategy
20 year Track Record of Sustained Buy and Build Growth
Covestus is actively looking to add new products and services to the Group through acquisition, in-licensing and distribution deals.
Our targets are already-marketed healthcare products and corporates, which can be medicines, medical devices, or medical cosmetics - serving consumer healthcare markets, prescription markets and the corporate wellness market - that offer patients and consumers therapeutically important products with a point of differentiation and innovation.
We seek opportunuties in the UK and Europe, but we also have excellent experience in China, the Far East and the USA.
The Covestus team has worked on over 40 M&A deals involving over £400m of investment over the last 20 years. We understand the need for low-distraction, effective DD and deal-making. We have an excellent track record that evidences the power of our approach.
Transactions are funded using cash reserves, debt finance and equity investment as appropriate and we have the financial support of high-quality healthcare investors.
Contact Us
Get in Touch
Please reach out to us regarding any of the brands or services in our Healthcare Group
Covestus Limited
Festival House, Jessop Avenue, Cheltenham, GL50 3SH, UK
Hours
Monday - Friday: 9am - 5pm
Saturday - Sunday: Closed
